Davis Capital Management’s Avanos Medical AVNS Stock Holding History

Davis Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$124	Buy	+5	New	+$117	﹤0.01%	1010

Other funds holding AVNS

Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Davis Capital Management's AVNS Position: Q2 2026 in Review

Davis Capital Management opened a new position in Avanos Medical (AVNS) in Q2 2026: 5 shares worth $124. The stake represents ﹤0.01% of the portfolio and ranks #1010 among its holdings.

54 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Davis Capital Management held 5 shares of Avanos Medical worth $124 as of Q2 2026.
Avanos Medical was a new Davis Capital Management position in Q2 2026.
Avanos Medical made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #1010 holding.
54 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.